AN
Anuh Pharma Ltd.
ANUHPHR.NS · NSE
₹90.95 -4.12% (-₹3.91)
1M +25.28%
Market Cap ₹9.52B
P/E Ratio 23.20x
Div. Yield 1.58%
ROE 12.55%
Valuation
58 /100
Fair P/S 1.23x
P/E 23.20x
P/B 2.70x
Growth
67 /100
Growing Book val. growth 13.45%
EPS growth 4.33%
Rev. growth 13.52%
Profitability
21 /100
Weak Op. margin 6.52%
Gross margin 17.41%
FCF margin 1.40%
Quality
67 /100
Excellent ROA 7.36%
ROIC 10.75%
Asset turnover 1.38x
Debt
100 /100
Low Int. coverage 106.58x
Debt/Equity 0.00x
Net debt/EBITDA -0.13x
Stability
66 /100
Moderate EPS volatility 48.15%
Beta 0.43x
Profitable years 4
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ANUHPHR.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ritesh Bipin Shah
Employees
323
Headquarters
Mumbai